At the National Association of
Chain Drug Stores Pharmacy
and Technology Conference
this past August, Pharmacy Times
brought industry leaders together for a
roundtable discussion on pharmacy
automation. Panelists discussed the
impact automation has already had on
pharmacy and how an increased
dependence on automation will affect
the practice of pharmacy in the future.
Panelists felt that automation is no
longer a luxuryit is a necessity in a
demanding marketplace in which
pharmacists struggle to keep pace with
the rising volume of prescriptions. "If
you look at the industry in general,"
said one panelist, "you have pressures
to lower costs and at the same time
pressures to add more services."
Although panelists loved the idea of
what automated systems can do for
their business, they said that choosing
the right system for a particular pharmacy's
needs is not simple. Panelists
agreed that, when it comes to choosing
an automated system, one size just
does not fit all.
Vendors, panelists said, do a good job
of providing the industry with choices
and suitable ways of integrating different
pieces of automation into the workflow.
Yet panelists advised pharmacists
to have a clear idea of how a system will
be used and to choose a vendor with a
strategic partnership in mind.
Automated pharmacy systems, panelists
said, free pharmacists from mundane
tasks and allow them to spend
more time with patients. Panelists
credited automation with introducing
more standardization, process control,
and checks and balances as well.
Although automation also is credited
with improving safety, panelists felt
that pressure will increase on the
industry to introduce standards to prevent
potential cross-contamination.
The Panel
- Fred M. Eckel, RPh, MS, Moderator,
Professor and Director, Office of Practice
Development and Education,
School of Pharmacy, University of
North Carolina at Chapel Hill, and
Editor-in-Chief of Pharmacy Times
- Michael E. Coughlin, President and
Chief Executive Officer, ScriptPro
- Mark Gregory, Vice President,
Pharmacy and Government
Affairs, Kerr Drug Inc
- Vanessa A. Jacobsen, PharmD,
Manager, Medication Use Evaluation,
Walgreens Health Initiatives
- Pete Klein, Vice President, Industry
Relations, Parata Systems
- Stephen Mitchell, MS, RPh, Vice
President, Marketing, AutoMed
Technologies Inc.
- Samuel L. Nebiolo, Director, Product
Management, McKesson Automated
Prescription Systems
- Jeff Newell, RPh, Chief Operating
Officer, Rhode Island Quality Partners
- Dan Villa, RPh, Vice President, Corporate
Development, Kinney Drug
- Bruce Wiswell, Director, Pharmacy
Operations/Technology, Rite Aid
An Excerpt from the Discussion
Fred Eckel (FE): Why has so much
attention been paid to automation of the
dispensing operation in pharmacy?
Michael Coughlin (MC): Pharmacy is
under a lot of economic pressure and is
economically vulnerable today. Changing
business models are pretty much a
given in this industry, yet many of the
challenges the industry faces are out of
its control. Technology is one area the
industry can control. And technology
can do some pretty powerful things for
pharmacy.
FE: As the number of prescriptions has
grown, the number of pharmacists dispensing
hasn't kept pace. Is that another
reason why automation is coming into
play?
Dan Villa (DV): It's also a quality-oflife
issue for the pharmacist. The volumes
were getting so high in the stores
that pharmacists just couldn't keep up,
even when a technician was added.
Automation can take the pressure off
and give them more time to spend
with the patients, and that's what
we're trying to do.
Bruce Wiswell (BW): I really believe
that we're trying to give pharmacists an
opportunity to differentiate themselves.
As we're all facing managed care issues,
it really doesn't matter where patients
go for a prescription. They're going to
get covered by insurance somewhere,
and we believe that if you're going to
differentiate yourself from mail order,
you have to do something different.
That's what automation for us is really
aboutgiving a pharmacist time.
FE: What impact does automation
have in the safety arena?
Jeff Newell (JN): Automated systems
compound the ability to be safe each
and every time a prescription is being
dispensed.
Stephen Mitchell (SM): I think
automation gives pharmacists the
opportunity to introduce more standardization,
more process control,
more checks and balances, without
extending the time it takes to introduce
those new activities.
FE: Is providing a safer practice something
pharmacists see as enhancing their
practice?
SM: There are many facets to what
you describe as safety. It could start
right on the front end in transcription
of the prescription. And again, if you
can let the pharmacist have more time
to interact and become a clinical
expert, you can eliminate a lot of problems
downstream.
JN: I think the need to avoid potential
cross-contamination in robotic systems
is absolutely a standard that
ought to be established going forward,
and I think there's going to be pressure
to establish that.
FE: How much penetration has already
occurred with dispensing automation?
SM: All of the other pharmacy practice
settings had very specific and clearly
obvious operational needs imposed
on them (hospitals with unit-dose dispensing,
long-term care with punch
cards, mail order with just the sheer volume
of transactions). Without automation,
they would have been unable to
move forward. The retail market is just
beginning to appreciate the impact of
automation and pharmacy efficiency
on reimbursement and labor challenges
as well as accuracy and profitability.
FE: So there's still real opportunity for
growth.
MC: There is real pressure on pharmacy
to get dispensing costs down to a
level that's competitive in the industry.
Pharmacy has to use technology to
push back by being more efficient.
Having integrated systems allows community
pharmacists to work at a higher
level. It also gives them a way to differentiate
themselves in the
marketplace.
FE: How do we justify newer automated
dispensing devices in community pharmacy?
Is it still about people replacement, or
are there other ways that we're justifying
this investment?
BW: I don't view it as saving labor.
We're just trying to catch up. By the
time you're getting that automated
device in the store, the pharmacists are
already in great need of that help. So
we're only trying to gain the time back,
for the pharmacists to get back to doing
what they were really supposed to do.
SM: From a pure labor perspective,
shifting the work from the expensive
pharmacist to the more inexpensive
technician is a big opportunity and
something that drives a lot of the ROI
[return on investment].
Samuel Nebiolo (SN): At the end of
the day, you're not looking to replace
people with automation. You're looking
to make them more effective, so
they give better services to the end
user. You know, less wait times, better
clinical reviews, and things like that.
At the same time, you're lowering the
cost of your prescriptions.
BW: Sometimes pharmacists become
the limiting step. Pharmacists need to
accept the technician and help the
technician do the job. Then the pharmacists
can get on with the business of
doing the job they should be doing.
DV: In the last store I worked in, 12
years ago, I was pounding away on the
keyboard, and this young technician
said, "Would you please move down
the counter?"When I asked why, she
said, "I can type with all my fingers,
and I'm very accurate, so if you move
down to the end of the counter and
check the prescriptions, we won't have
people waiting here."So I moved.
From that day forward, I really understood
the value of technicians. They
really drive the business.
FE: How do pharmacies begin evaluating
automation systems?
SM: There isn't one magic bullet in
every single situation. I think you have
to spend the time talking to the experts.
MC: We found that pharmacists
have been very willing to share their
experiences and invite someone to
come in and mentor them through the
process. Vendors can also provide peer
comparisons.
Pete Klein: One of the most important
things is to have a vision of where
you're going to be after automation is in
place. You have to understand exactly
what parts of your everyday life it's
going to impact. And when that impact
is realized, what are you going to do
with that time? What's going to change,
and do you have a plan in place?
FE: How are board regulations today
impacting either positively or negatively in
the whole automation dispensing process?
DV: The New York board looks at
automation as an integral part of the
profession of pharmacy. Boards know
that automation really does 2 things: it
gives the pharmacist time with the
patient, and it provides quality control.
So I think the boards are supportive.
FE: What will the future hold for pharmacists
as a result of automation?
DV: Graduating pharmacists have such
a high knowledge level that the ability for
them to really make a difference in the
patients'lives is going to be great. And I
think that if we can let automation and
technicians do the filling and let the
pharmacists manage the disease states, it's
a great time to be a pharmacist.
JN: Pharmacists are going to have
new tools, automation tools, physician
order entry. That's going to provide
more data, so they have to become
almost organizational experts in the
way to manage their environment.
Down the road, I would hope that a
high-level paraprofessional technician
manages that whole mechanical function,
and pharmacists almost run a business
around pharmaceutical care. It's
not just about the product any more.
SM: The vision of pharmacy has to be
in cognitive services. It has to evolve into
being viewed as an integral part of the
health care team. The role of automation
is to enhance techniques, provide better
safety, provide flexibilities, provide better
utilization of the resources pharmacists
have to improve their cost containment.
But I think automation also has to be
very flexible, very integrated. It has to be
adaptable to a variety of situations. It
isn't one pharmacy and one solution
that fits all. And that's a challenge for us.
SN: Market forces are present, and
technology is coming into play more
and more. We all need to view this not
as a customer-vendor issue to resolve,
but a partnership, in order to address
these issues. It's a necessity for the vendors
and us to get together and form
that partnership to look at business
solutions. We should not look at selling
products and pieces, but look at solutions
to provide these better healthcare
services to the consumer market.
MC: Retail pharmacy is a business,
it's a retail business. It's under a lot of
stress right now, and that's likely to
continue, because it's an important
part of the health care system, and the
health care system everywhere is under
pressure. We have to equip retail pharmacies
to operate with integrated business
systems. Those systems need to
transform community pharmacy into
more of a profit-margin-producing
engine. There are opportunities to produce
not just volume, because volume
without profit margin is no good.
We've seen too much of that.
BW: The vendors are doing a great
job of providing us with choices, suitable
ways to integrate different pieces
of automation into our workflows. I
think it's up to us to learn to use them
and to really take advantage of them
and to take advantage of them at the
appropriate times. And I think that's
probably where retail might be most
behind, in the appropriate timing of
using what's available.
JN: When pharmacists want to automate,
they need to make sure they're
looking at their selection with a strategic
partner in mind: where are they
going, what do they want out of that
relationship?
DV: Automation in the future is going
to do a number of things for us. It's
improving the quality of the product,
and it's giving us time to spend with our
customers. Customers know a lot about
their medications, but they still come to
us to ask for more information. If the
pharmacist has more time to spend with
the patients out in the OTC aisles, it
brings in extra sales. So I think it's a great
time for pharmacy.
Ms. Sax is a freelance writer based in
Ridgewood, NJ.